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Abstract
Background: Intestinal schistosomiasis due to Schistosoma mansoni was first reported in Oman in 1979. We
describe the trend in parasitological and serological prevalence of human infection with S. mansoni in the endemic
area over the period 1982–2014, and the compliance of data generated by the national monitoring and evaluation
system with schistosomiasis elimination criteria set by the Ministry of Health of Oman.
Methods: Parasitological and serological assessments were carried out on population (mainly children) living in the
area at risk for schistosomiasis in Dhofar, the country’s only endemic Governorate, for a period of over 30 years.
Kato-Katz thick smear and Indirect Haemagglutination Assay were the techniques employed.
Results: Data indicate a progressive decline in prevalence of S. mansoni throughout the 1980s and the 1990s, a
recrudescence in the early 2000s, and a more marked decrease following the implementation of six rounds of mass
treatment with praziquantel from 2007 to 2013. Latest parasitological prevalence (2011) was 0%, while latest
serological prevalence (2014) was 0.11%.
Conclusion: Transmission of schistosomiasis has reached very low levels in Oman. Elimination criteria established
by the Ministry of Health of Oman (parasitological prevalence ≤ 1% and serological prevalence≤ 5%) have been
met since 2008. Further investigations are required to assess whether interruption of transmission has been
achieved in some or all foci, in view of the establishment of a formal verification process under the auspices of
WHO.
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Background
Schistosomiasis and its elimination
Schistosomiasis is a blood-fluke (trematode) infection
characterized by two major clinical presentations. Schis-
tosoma mansoni, S. mekongi, S. intercalatum and S. japo-
nicum are responsible for intestinal schistosomiasis,
while S. haematobium causes urogenital schistosomiasis
[1]. The burden of schistosomiasis is still significant in
many parts of the world; however several countries have
reached a low-endemic status [2]. Since the adoption of
World Health Assembly Resolution WHA65.21 on
“elimination of schistosomiasis” [3], and the release of
the Schistosomiasis Strategic Plan 2012–2020 [2], WHO
encourages low-burden countries to embark in the “final
push” and cut transmission of schistosomiasis, thus
achieving its elimination, through an inter-sectorial ap-
proach encompassing preventive chemotherapy, snail
control, environmental management, health education,
access to safe water, and sanitation.
As Oman is one of such countries, we aim to describe
the trend in levels of parasitological and serological preva-
lence of human infection with S. mansoni over the period
1982–2014, and we discuss the compliance of data gener-
ated by the national monitoring and evaluation system
with elimination criteria set by the Ministry of Health of
Oman, as well as the steps required to further document
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Fig. 1 Map of Oman (in red: schistosomiasis endemic area in Dhofar Governorate)
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interruption of S. mansoni transmission in the country, in
view of the expected establishment of a formal verification
process to be carried out under the auspices of WHO.
Schistosomiasis in Oman
Both Schistosoma mansoni and Schistosoma haemato-
bium are endemic in the Arabian peninsula, notably in
Saudi Arabia and Yemen [4, 5].
In Oman, transmission of intestinal schistosomiasis
due to S. mansoni has been documented only in Dhofar
Governorate, and was first reported in 1979. Biompha-
laria arabica (a strain of B. pfeifferi) has been identified
as the snail intermediate host, and since 1896 has been
observed in Dhofar, where its distribution is limited to
few foci only. Extensive malacological investigations have
shown that B. arabica is not present elsewhere in Oman
and that no other Biomphalaria species is found in the
country, [6–10] thus excluding the possibility of trans-
mission of S. mansoni outside Dhofar.
Although the snail Bulinus wrighti, a potential inter-
mediate host of S. haematobium, is present in Dhofar
[10, 11] as well as in other limited areas of the coun-
try [12], transmission of S. haematobium has never
been found to occur in Oman, and no autochthonous
cases of urinary schistosomiasis have ever reported by
the country [13, 14].
Dhofar lies in south-western Oman, bordering Yemen.
It is a rather mountainous region covering 99 300 sq km
(38 300 sq mi) (Fig. 1), with a population of approximately
375 000. Dhofar’s weather is relatively cool and rainy even
during the summer (July to September, e.g., in July, mean
daily temperature = 26.4 °C, mean rainfall 24.5 mm).
Schistosomiasis transmission sites include temporary and
permanent, natural and artificial water bodies and river-
beds (wadis) located in a relatively small (80 km× 20 km),
hilly area along the coast of the Indian Ocean [15] (Figs. 2
and 3). Such area lies within 20 km from the seashore,
and is comprised in the wilayat (provinces) of Salalah,
Taqah and Mirbat. Water contact used to be related to do-
mestic activities but now mainly occurs for recreational
purposes, although shepherds might bring their animals
to water bodies, thus having occasional contacts. Human
population in the area at risk for schistosomiasis is esti-
mated at 25 000, including Omanis and non-Omanis.
In Dhofar, epidemiology of schistosomiasis has been
monitored through an extensive active surveillance
screening system. Passive surveillance is also in place;
schistosomiasis is a notifiable disease under group B-
Communicable Diseases, which means that suspect or
confirmed cases detected through the routine health ser-
vices of Oman have to be reported within a week time
[16]. While a few cases of both S. mansoni and S. hae-
matobium infection are still passively detected every year
in several Governorates among non-Omanis and
Omanis alike, thorough investigations have led to the
conclusion that none, among the cases occurred in re-
cent years, acquired the infection in Oman; as such they
were all considered imported. The last passively-
detected autochthonous case occurred in 2007: a case of
intestinal schistosomiasis from Dhofar governorate [14].
Schistosomiasis control in Dhofar
Epidemiological investigations on schistosomiasis, as
well as planning of public-health measures to tackle the
disease, followed the detection of the first two cases of
schistosomiasis, at Sultan Qaboos Hospital in Salalah, in
1979 [15]. Starting in 1982, all water bodies in Dhofar
were systematically screened for presence of B. arabica,
which revealed presence of the snail in a total of 22
water bodies out of 120, most of which were located in
remote mountainous areas, and difficult to reach [17].
An inter-sectorial control strategy was consequently
launched in 1983. It included snail control by
Fig. 2 Natural water body in hilly Dhofar (WHO/AF Gabrielli)
Fig. 3 Artificial water body used for recreational purposes
(WHO/AF Gabrielli)
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mollusciciding with niclosamide (Bayluscide®); environ-
mental modification of water bodies (embanking; build-
ing public latrines and increasing access to potable
water); health education relying on different media chan-
nels including notice signs advising the population not
to enter water in reason of the risk of schistosomiasis
(Fig. 4); and population screening and treatment of posi-
tive cases.
While transmission appeared largely under control
during the 1990s, a recrudescence in 2000–2001 trig-
gered the adoption of a schistosomiasis elimination
strategy relying on mass treatment with praziquantel.
The strategy was launched by the Ministry of Health in
2003, with support from the World Health Organization.
Elimination targets were set by the Ministry of Health of
Oman and defined as parasitological prevalence ≤ 1% by
Kato-Katz thick smear and serological prevalence ≤ 5%
by Indirect Haemagglutinantion Assay (IHA), to be
achieved in Dhofar Governorate by 2012 [MoH, unpub-
lished]. Six rounds of mass treatment with praziquantel
40–60 mg/kg targeting children and adults were imple-
mented at approximately annual intervals between April
2007 and September 2013 (treated population ranged
between 4 000 and 15 000; see Table 1). Over this
period, complementary public-health interventions con-
tinued to be implemented but on a lesser scale, although
tilapia fish were introduced in some water bodies for
biological control of snails. Health education activities
consisted in renovating existing notice signs and intro-
ducing new ones, and in providing similar messages to
children in school (through health education sessions)
and adults in health centres (through posters, and health
staff ’s advice).
Methods
From 1982 to 2011, schistosomiasis trends were moni-
tored through active parasitological screenings of popu-
lation living in the endemic areas (both Omani and
expatriates), mainly schoolchildren aged 6–17 years, an
exercise that was followed by treatment of positive cases
and, from 2007, by the implementation of mass chemo-
therapy with praziquantel in selected areas.
From 2001 onwards, yearly serological assessments were
also implemented among schoolchildren (all Omani). As
such, between 2001 and 2011, both stool and serological
assessments were carried out. As in 2011 no individuals
were found to test positive to stool examination, the
Ministry of Health decided to stop parasitological screen-
ing and only rely on serological investigations.
Between 1982 and 2011, stool samples were collected
by sanitary inspectors and processed at the Governorate
Public Health Laboratory in Salalah, the capital city of
Dhofar. The technique employed was Kato-Katz thick
smear [18].
Serological assessments were conducted among
schoolchildren every year between 2001 and 2014.
Schools were selected from affected localities in the
wilayats of Salalah, Taqah, and Mirbat. The last survey
conducted prior to the commencement of mass treat-
ment interventions was implemented in 2007; the last
one in 2014, 1 year after the last distribution of prazi-
quantel. The inclusion criteria were (i) 7th grade students
(12–14 years old) at the time of the survey; (ii) from
schools located in endemic areas in Dhofar Governorate
(i.e. from selected localities in the area suspect for active
transmission). The exclusion criteria were (i) student not
registered in 7th grade, (ii) unwillingness to participate
or (iii) impossibility to take blood sample for any reason.
Children recruited in serological monitoring and
evaluation activities were asked to provide blood samples
for serological screening by IHA [19], with the aim of
detecting antibodies against adult S. mansoni worm anti-
gens, and thus documenting both current and past infec-
tion (elevated antibody levels are still detectable many
years after cure [20]). Blood samples were collected in
the field by health personnel and transported to the
Governorate Public Health Laboratory in Salalah for
processing.
The aim of the stool and serological screening was to
monitor trends in epidemiology of schistosomiasis, and,
from 2007 (baseline) onwards, to assess the impact of
Fig. 4 Sign advising not to enter water bodies (WHO/AF Gabrielli)
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mass chemotherapy with praziquantel over the following
years. Active surveillance by population screening was
meant to complement passive surveillance implemented
through the routine health services of Oman, based on
the consideration that the sensitivity of the latter strat-
egy would be too low to detect autochthonous cases of
schistosomiasis (who would most likely be asymptomatic
and of low intensity of infection in reason of its reduced
levels of transmission).
Results
Table 2 and Fig. 5 show numbers screened and testing
positive by type of examination, between 1982 and 2014,
and the corresponding levels of parasitological and sero-
logical prevalence of infection. Overall, a decreasing
trend in both parasitological prevalence and seropreva-
lence of S. mansoni infection was observed among
screened individuals in Dhofar Governorate during the
period under study.
An increase in parasitological prevalence was however
observed from the early 2000s, after several years during
which the number of detected cases was very small. This
finding reflects the reintroduction of transmission in
rural areas of Salalah wilayat, a fact confirmed by the de-
tection of infected B. arabica snails in the relevant water
bodies, several year after the last specimen had been
found [MoH, unpublished]. The causes of such recru-
descence remain unclear, although suspicions point ei-
ther to a rodent reservoir, based on the consideration
that Rattus rattus was found to be naturally infected
with S. mansoni in Dhofar [17], or to reintroduction of
transmission by travellers from neighbouring countries
(e.g. Yemen was then highly endemic for S. mansoni).
Following the adoption of a mass-treatment-based elim-
ination strategy by the health authorities of Oman, a sta-
tistically significant decrease (P < 0.001) in prevalence
was observed between 2007 (last stool investigation con-
ducted prior to the start of mass treatment) and the fol-
lowing years (2008–2011). Over such 4-year period, only
zero or one cases were detected during each survey,
compared to 15 cases in 2007.
Serological trends also show a progressive decrease in
prevalence. Notably, the last survey conducted prior to
the start of mass chemotherapy, in 2007, indicated that
out of 3 210 children serologically screened, 48 were
positive (1.49%). In 2014, following the completion of six
rounds of praziquantel mass chemotherapy, 3 608 chil-
dren were serologically tested and only four found to be
positive (0.11%). The decrease in prevalence of infection
observed between 2007 and 2014 is statistically signifi-
cant (P < 0.001).
Discussion
A parasitological prevalence ≤ 1% by Kato-Katz and a
serological prevalence ≤ 5% by IHA, in 2006 were
achieved in Dhofar in 2008 and 2006, respectively. As
such, as of 2008, the country is compliant with both na-
tional elimination criteria set by the Ministry of Health
of Oman (although WHO rather employs the term elim-
ination to refer to the actual interruption of transmission
[2]). The irregular but progressive decrease of parasito-
logical prevalence, and the less rapid, but steady decline
of serological prevalence of S. mansoni infection in areas
at risk in Dhofar reflect the different phases experienced
by Oman in its fight against schistosomiasis: the gradual
reduction of risk of acquiring new infections in the
1980s–1990s as a probable consequence of the inter-
sectorial control measures applied; the recrudescence
observed in the early 2000s; and finally the impact on
transmission registered from 2007 onwards, as a prob-
able consequence of the implementation of the six
rounds of mass treatment conducted until 2013.
Conclusion
Transmission of schistosomiasis has reached very low
levels throughout the area at risk in Oman; consider-
ing that serological assessments detect both current
and past infections, transmission might in fact have
been interrupted in some or all foci already. Add-
itional investigations are therefore required to ensure
collection of evidence that would sustain the country’s
claim that schistosomiasis has been eliminated, and
would enable Oman to access the WHO’s formal
Table 1 Mass chemotherapy with praziquantel, 2007 – 2013
Round Year Wilayat Target population Population treated
1st April 2007 Salalah Schoolchildren 4,302
2nd October 2007 Salalah Schoolchildren and adults
3rd 2008 Salalah Schoolchildren and adults 5,148
- 2009 - Not Implemented 0
4th 2010 Taqah Schoolchildren and adults 1,760
5th 2011 Salalah, Taqah, Mirbat Schoolchildren and adults 15,795
6th and final round 2013 Taqah, Mirbat Schoolchildren and adults 4,960
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process to verify interruption of transmission, which
is currently being established [A. Garba, personal
communication].
In line with other countries which have achieved low
transmission of Schistosoma spp. infection, such investiga-
tions should be systematically implemented throughout
the area at-risk, and should rely on sensitive procedures
able to rule out continuing transmission. Such proce-
dures include molecular detection of S. mansoni
cercariae in snail intermediate hosts [20], as well as
assessment of current infection in human populations,
through detection of antigens to S. mansoni (e.g. by
circulating cathodic antigen (CCA) tests) [21, 22], or
through stool sedimentation coupled with miracidia
hatching test [23].
Should transmission of S. mansoni be shown to
continue in Dhofar, although at low levels, an aggres-
sive strategy would be required, relying on mass
Table 2 Number of schistosomiasis cases actively detected annually in Dhofar: 1982 – 2014
Year Stool Examination Serology Test
Number screened Omani positive Non-Omani positive Total positive Number screened Positive (all Omani)
1982 2,038 16 7 23 (1.12%) – –
1983 7,278 4 6 10 (0.13%) –
1984 3,880 4 6 10 (0.25%) – –
1985 3,352 16 24 40 (1.19%) – –
1986 5,663 10 10 20 (0.35%) – –
1987 3,977 3 7 10 (0.25%) – –
1988 5,642 2 3 5 (0.08%) – –
1989 2,739 2 1 3 (0.1%) – –
1990 2,645 3 0 3 (0.11%) – –
1991 1,500–2,000 0 0 0 – –
1992 1,500–2,000 0 0 0 – –
1993 1,500–2,000 0 0 0 – –
1994 1,500–2,000 0 0 0 – –
1994 1,500–2,000 0 0 0 – –
1996 654 2 0 2 (0.3%) – –
1997 444 0 0 0 – –
1998 200 1 0 1 (0.5%) – –
1999 168 1 0 1 (0.59%) – –
2000 578 13 0 13 (2.24%) – –
2001 800 36 0 36 (4.5%) 511 139 (27.2%)
2002 1,237 81 1 82 (6.62%) 305 72 (23.6%)
2003 796 81 0 81 (10.17%) 2 418 287 (11.86%)
2004 748 14 0 14 (1.87%) 3 745 413 (11.02%)
2005 763 15 0 15 (1.96%) 5 633 551 (9.78%)
2006 448 5 3 5 (1.78%) 2 639 42 (1.59%)
2007 165 15 0 15 (9.09%) 3 210 48 (1.49%)
Start of mass treatment with praziquantel
2008 167 1 0 1 (0.59%)* 9 188 165 (1.79%)
2009 265 0 0 0 3 024 28 (0.92%)
2010 246 1 0 1 (0.4%)* 3 265 136 (4.16%)
2011 109 0 0 0 2 988 63 (2.10%)
2012 – – – – 2 513 51 (2.02%)
2013 – – – – 2 788 14 (0.50%)*
2014 – – – – 3 608 4 (0.11%)*
(*) Statistically-significant reduction from 2007 values
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chemotherapy with praziquantel in all remaining foci
coupled with a renewed effort on complementary
public health interventions such as snail control, en-
vironmental management, improved sanitation, safe
water supply, and health education. In case of success-
ful verification of the schistosomiasis-free status, post-
elimination surveillance would need to be implemented
with the aim of detecting any new case and preventing
reintroduction of transmission in Dhofar, at least until all
neighbouring endemic countries will have achieved the
same goal [2]. The experience accumulated by health
authorities of Oman in controlling and monitoring schis-
tosomiasis for a period of over 30 years will certainly
prove useful in either endeavor.
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Fig. 5 Decline of parasitological and serological prevalence of infection with S. mansoni in Dhofar
Box 1 Timeline of facts and activities related to schistosomiasis in Oman
1970s/1980s – Malacological investigations define geographical areas of Oman where snail intermediate hosts of Schistosoma spp. can
be found
1979 – First cases of S. mansoni infection detected in Dhofar Governorate, Oman
1982 – Systematic screening of water bodies in Dhofar Governorate for presence of B. arabica; active surveillance by systematic stool
examination is initiated
1983 – An inter-sectorial control strategy is launched by the Ministry of Health
1990s – Incidence of infection reaches very low levels
2001 – Active surveillance by systematic serological surveys is initiated
2003 – An elimination strategy relying on mass treatment is launched following a recrudescence in transmission
2007 – The last parasitological autochthonous case is detected through passive surveillance; mass chemotherapy with praziquantel is
initiated
2010 – The last parasitological autochthonous case is detected through active surveillance
2012 – Active surveillance by systematic stool examination is discontinued
2014 – Mass chemotherapy with praziquantel is discontinued
2015 – Active surveillance by systematic serological surveys is suspended while MoH is planning the implementation of surveys aimed at
confirming interruption of transmission
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